REPLIMUNE GROUP, INC. General and Administrative Expense
REPLIMUNE GROUP, INC. (REPL) reported General and Administrative Expense of $18.73 million for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2026-02-03
- REPLIMUNE GROUP, INC. general and administrative expense for the quarter ending 2025-12-31 was $18.73M, a 3.96% increase year-over-year.
- REPLIMUNE GROUP, INC. general and administrative expense for the quarter ending 2025-09-30 was $26.41M, a 70.77% increase year-over-year.
- REPLIMUNE GROUP, INC. general and administrative expense for the quarter ending 2025-06-30 was $32.58M, a 126.32% increase year-over-year.
- REPLIMUNE GROUP, INC. general and administrative expense for the quarter ending 2025-03-31 was $25.35M, a 56.72% increase year-over-year.
- REPLIMUNE GROUP, INC. general and administrative expense for fiscal 2025 was $72.18M, a 20.68% increase from fiscal 2024.
- REPLIMUNE GROUP, INC. general and administrative expense for fiscal 2024 was $59.81M, a 18.31% increase from fiscal 2023.
- REPLIMUNE GROUP, INC. general and administrative expense for fiscal 2023 was $50.55M, a 30.40% increase from fiscal 2022.
- REPLIMUNE GROUP, INC. general and administrative expense for fiscal 2022 was $38.77M, a 67.10% increase from fiscal 2021.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $18.73M 10-Q · filed 2026-02-03 | $45.14M derived: sum of 2 quarters · filed 2026-02-03 | $77.72M 10-Q · filed 2026-02-03 | $103.07M derived: sum of 4 quarters · filed 2026-02-03 |
| 2025-09-30 | $26.41M 10-Q · filed 2025-11-06 | $58.99M 10-Q · filed 2025-11-06 | $84.35M derived: sum of 3 quarters · filed 2025-11-06 | $102.36M derived: sum of 4 quarters · filed 2026-02-03 |
| 2025-06-30 | $32.58M 10-Q · filed 2025-08-07 | $57.93M derived: sum of 2 quarters · filed 2025-08-07 | $75.95M derived: sum of 3 quarters · filed 2026-02-03 | $91.42M derived: sum of 4 quarters · filed 2026-02-03 |
| 2025-03-31 | $25.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $43.37M derived: sum of 2 quarters · filed 2026-02-03 | $58.84M derived: sum of 3 quarters · filed 2026-02-03 | $72.18M 10-K · filed 2025-05-22 |
| 2024-12-31 | $18.02M 10-Q · filed 2026-02-03 | $33.48M derived: sum of 2 quarters · filed 2026-02-03 | $46.83M 10-Q · filed 2026-02-03 | $64.06M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $15.47M 10-Q · filed 2025-11-06 | $29.86M 10-Q · filed 2025-11-06 | $46.04M derived: sum of 3 quarters · filed 2025-11-06 | $59.73M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $14.39M 10-Q · filed 2025-08-07 | $30.57M derived: sum of 2 quarters · filed 2025-08-07 | $44.27M derived: sum of 3 quarters · filed 2025-08-07 | $58.99M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $16.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $29.87M derived: sum of 2 quarters · filed 2025-05-22 | $44.60M derived: sum of 3 quarters · filed 2025-05-22 | $59.81M 10-K · filed 2025-05-22 |
| 2023-12-31 | $13.69M 10-Q · filed 2025-02-12 | $28.42M derived: sum of 2 quarters · filed 2025-02-12 | $43.63M 10-Q · filed 2025-02-12 | $58.67M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $14.73M 10-Q · filed 2024-11-12 | $29.94M 10-Q · filed 2024-11-12 | $44.98M derived: sum of 3 quarters · filed 2024-11-12 | $56.35M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $15.21M 10-Q · filed 2024-08-08 | $30.25M derived: sum of 2 quarters · filed 2024-08-08 | $41.62M derived: sum of 3 quarters · filed 2024-08-08 | $54.37M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $15.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $26.41M derived: sum of 2 quarters · filed 2024-05-16 | $39.16M derived: sum of 3 quarters · filed 2024-05-16 | $50.55M 10-K · filed 2024-05-16 |
| 2022-12-31 | $11.37M 10-Q · filed 2024-02-08 | $24.11M derived: sum of 2 quarters · filed 2024-02-08 | $35.51M 10-Q · filed 2024-02-08 | $45.76M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $12.74M 10-Q · filed 2023-11-07 | $24.14M 10-Q · filed 2023-11-07 | $34.40M derived: sum of 3 quarters · filed 2023-11-07 | $44.74M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $11.40M 10-Q · filed 2023-08-03 | $21.65M derived: sum of 2 quarters · filed 2023-08-03 | $32.00M derived: sum of 3 quarters · filed 2023-08-03 | $41.34M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $10.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $20.60M derived: sum of 2 quarters · filed 2023-05-18 | $29.94M derived: sum of 3 quarters · filed 2023-05-18 | $38.77M 10-K · filed 2023-05-18 |
| 2021-12-31 | $10.35M 10-Q · filed 2023-02-09 | $19.69M derived: sum of 2 quarters · filed 2023-02-09 | $28.52M 10-Q · filed 2023-02-09 | $34.48M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $9.35M 10-Q · filed 2022-11-03 | $18.17M 10-Q · filed 2022-11-03 | $24.13M derived: sum of 3 quarters · filed 2022-11-03 | $30.08M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $8.83M 10-Q · filed 2022-08-04 | $14.79M derived: sum of 2 quarters · filed 2022-08-04 | $20.74M derived: sum of 3 quarters · filed 2022-08-04 | $26.35M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | $11.91M derived: sum of 2 quarters · filed 2022-05-19 | $17.52M derived: sum of 3 quarters · filed 2022-05-19 | $23.20M 10-K · filed 2022-05-19 |
| 2020-12-31 | $5.95M 10-Q · filed 2022-02-03 | $11.57M derived: sum of 2 quarters · filed 2022-02-03 | $17.24M 10-Q · filed 2022-02-03 | $22.44M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | $5.61M 10-Q · filed 2021-11-04 | $11.29M 10-Q · filed 2021-11-04 | $16.49M derived: sum of 3 quarters · filed 2021-11-04 | $21.20M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $5.68M 10-Q · filed 2021-08-06 | $10.87M derived: sum of 2 quarters · filed 2021-08-06 | $15.59M derived: sum of 3 quarters · filed 2021-08-06 | $19.66M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | $9.91M derived: sum of 2 quarters · filed 2021-05-20 | $13.99M derived: sum of 3 quarters · filed 2021-05-20 | $17.44M 10-K · filed 2021-05-20 |
| 2019-12-31 | $4.72M 10-Q · filed 2021-02-04 | $8.79M derived: sum of 2 quarters · filed 2021-02-04 | $12.24M 10-Q · filed 2021-02-04 | $14.65M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $4.07M 10-Q · filed 2020-11-05 | $7.52M 10-Q · filed 2020-11-05 | $9.94M derived: sum of 3 quarters · filed 2020-11-05 | $12.22M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $3.45M 10-Q · filed 2020-08-07 | $5.86M derived: sum of 2 quarters · filed 2020-08-07 | $8.14M derived: sum of 3 quarters · filed 2020-08-07 | $10.29M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $4.69M derived: sum of 2 quarters · filed 2020-06-03 | $6.83M derived: sum of 3 quarters · filed 2020-06-03 | $8.77M 10-K · filed 2020-06-03 |
| 2018-12-31 | $2.28M 10-Q · filed 2020-02-13 | $4.42M derived: sum of 2 quarters · filed 2020-02-13 | $6.36M 10-Q · filed 2020-02-13 | $8.93M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-09-30 | $2.14M 10-Q · filed 2019-11-12 | $4.08M 10-Q · filed 2019-11-12 | $6.65M derived: sum of 3 quarters · filed 2020-06-03 | $7.81M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-06-30 | $1.94M 10-Q · filed 2019-08-14 | $4.50M derived: sum of 2 quarters · filed 2020-06-03 | $5.66M derived: sum of 3 quarters · filed 2020-06-03 | $6.77M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-03-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $3.72M derived: sum of 2 quarters · filed 2020-06-03 | $4.83M derived: sum of 3 quarters · filed 2020-06-03 | $5.71M 10-K · filed 2020-06-03 |
| 2017-12-31 | $1.16M 10-Q · filed 2019-02-14 | $2.27M derived: sum of 2 quarters · filed 2019-02-14 | $3.15M 10-Q · filed 2019-02-14 | |
| 2017-09-30 | $1.11M 10-Q · filed 2018-11-14 | $1.99M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $885.00K 10-Q · filed 2018-08-30 | |||
| 2017-03-31 | $2.71M 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |